Diagnostic imaging of hepatocellular carcinoma: recent progress (Q37972809)

26 August 2017

Diagnostic imaging of hepatocellular carcinoma: recent progress (English)

1 reference

26 August 2017

0 references

hepatocellular carcinoma

1 reference

Masatoshi Kudo

1

0 references

publication date

22 December 2011

1 reference

26 August 2017

1 reference

26 August 2017

81 Suppl 1

1 reference

26 August 2017

73-85

1 reference

Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan

26 August 2017

1 reference

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.

21 January 2018

1 reference

Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.

21 January 2018

1 reference

Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images.

21 January 2018

1 reference

Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.

21 January 2018

1 reference

Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial.

21 January 2018

1 reference

Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.

21 January 2018

1 reference

Hepatic malignancies: Correlation between sonographic findings and pathological features

21 January 2018

1 reference

Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010.

21 January 2018

1 reference

Contrast-enhanced harmonic ultrasound imaging in ablation therapy for primary hepatocellular carcinoma

21 January 2018

1 reference

Local ablation therapy for hepatocellular carcinoma: current status and future perspectives

21 January 2018

1 reference

Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation

21 January 2018

1 reference

Radiofrequency ablation of hepatocellular carcinoma: Current status

21 January 2018

1 reference

Multidetector CT: diagnostic impact of slice thickness on detection of hypervascular hepatocellular carcinoma

21 January 2018

1 reference

Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT.

21 January 2018

1 reference

Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver?

21 January 2018

1 reference

Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis

21 January 2018

1 reference

Triple-phase MDCT of hepatocellular carcinoma.

21 January 2018

1 reference

Three-dimensional CT angiography of the hepatic artery: use of multi-detector row helical CT and a contrast agent.

21 January 2018

1 reference

Hepatic arteries in potential donors for living related liver transplantation: evaluation with multi-detector row CT angiography.

21 January 2018

1 reference

Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver

21 January 2018

1 reference

Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging

21 January 2018

1 reference

Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings

21 January 2018

1 reference

Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma.

21 January 2018

1 reference

Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi--gadoxetic acid-enhanced MR imaging

21 January 2018

1 reference

Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.

21 January 2018

1 reference

Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging

21 January 2018

1 reference

The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy

21 January 2018

1 reference

Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?

21 January 2018

1 reference

Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatoce

21 January 2018

1 reference

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia

21 January 2018

1 reference

Multistep human hepatocarcinogenesis: correlation of imaging with pathology

21 January 2018

1 reference

Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material

21 January 2018

1 reference

Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology

21 January 2018

1 reference

Defect Reperfusion Imaging, a Newly Developed Novel Technology using Sonazoid in the Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

Newly Developed Novel Ultrasound Technique, Defect Reperfusion Ultrasound Imaging, Using Sonazoid in the Management of Hepatocellular Carcinoma

21 January 2018

1 reference

Usefulness of the Post-Vascular Phase of Contrast-Enhanced Ultrasonography with Sonazoid in the Evaluation of Gross Types of Hepatocellular Carcinoma

21 January 2018

1 reference

Sonazoid-Enhanced Ultrasonography for Diagnosis of Hepatic Malignancies: Comparison with Contrast-Enhanced CT

21 January 2018

1 reference

Double-Contrast Ultrasound: A Novel Surveillance Tool for Hepatocellular Carcinoma

21 January 2018

1 reference

Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience

21 January 2018

1 reference

Radiofrequency Ablation for Hepatocellular Carcinoma: Assistant Techniques for Difficult Cases

21 January 2018

1 reference

What Is the Best Time to Evaluate Treatment Response after Radiofrequency Ablation of Hepatocellular Carcinoma Using Contrast-Enhanced Sonography?

21 January 2018

1 reference

Percutaneous Radiofrequency Ablation of Sonographically Unidentifiable Liver Tumors

21 January 2018

1 reference

Hepatic MR Imaging with Ferumoxides: Multicenter Study of Safety and Effectiveness of Direct Injection Protocol

21 January 2018

1 reference

Imaging Characteristics of Hepatocellular Carcinoma Using the Hepatobiliary Contrast Agent Gd-EOB-DTPA

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000333265

1 reference

26 August 2017

1 reference

PubMed ID

22212940